Ambra Bioscience Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.01M
Ambra Bioscience General Information
Description
Provider of dietary supplements and medical foods intended to help people control blood sugar levels. The company's supplements focus on the physiologic release of hormones produced by L-cells in the lower gut which affects hunger, glucose regulation, inflammatory response and mood, enabling people to maintain a healthy diet.
Contact Information
Website
www.ambrabio.comCorporate Office
- 3251 Sitio Avellana
- Carlsbad, CA 92009
- United States
Corporate Office
- 3251 Sitio Avellana
- Carlsbad, CA 92009
- United States
Ambra Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 31-Jul-2017 | $2.01M | Completed | Generating Revenue | ||
| 2. Angel (individual) | 26-Sep-2016 | Completed | Startup | |||
| 1. Seed Round | 02-Feb-2015 | $1.17M | $1.17M | Completed | Startup |
Ambra Bioscience Comparisons
Industry
Financing
Details
Ambra Bioscience Competitors (2)
One of Ambra Bioscience’s 2 competitors is Nutrisystem, a Private Equity-Backed company based in Fort Washington, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nutrisystem | Private Equity-Backed | Fort Washington, PA | ||||
| WW | Formerly PE-Backed | New York, NY |
Ambra Bioscience Patents
Ambra Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210084956-A1 | Compositions and methods for hunger control and weight management | Inactive | 23-Feb-2018 | ||
| EP-2916828-A1 | Gras enteric coating formulations and methods of making and using same | Inactive | 07-Nov-2012 | ||
| US-9486463-B2 | Chemosensory receptor ligand-based therapies | Inactive | 19-Oct-2010 | ||
| US-20120094942-A1 | Chemosensory receptor ligand-based therapies | Active | 19-Oct-2010 | ||
| US-20150150894-A1 | Chemosensory receptor ligand-based therapies | Active | 20-Apr-2009 | A61K31/7016 |
Ambra Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ambra Bioscience FAQs
-
When was Ambra Bioscience founded?
Ambra Bioscience was founded in 2014.
-
Where is Ambra Bioscience headquartered?
Ambra Bioscience is headquartered in Carlsbad, CA.
-
What is the size of Ambra Bioscience?
Ambra Bioscience has 15 total employees.
-
What industry is Ambra Bioscience in?
Ambra Bioscience’s primary industry is Food Products.
-
Is Ambra Bioscience a private or public company?
Ambra Bioscience is a Private company.
-
What is Ambra Bioscience’s current revenue?
The current revenue for Ambra Bioscience is .
-
How much funding has Ambra Bioscience raised over time?
Ambra Bioscience has raised $3.82M.
-
Who are Ambra Bioscience’s competitors?
Nutrisystem and WW are competitors of Ambra Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
